You just read:

New England Journal of Medicine Publishes Results of Ebola Clinical Trial Confirming Superiority of Regeneron's REGN-EB3 to ZMapp in Preventing Ebola Deaths

News provided by

Regeneron Pharmaceuticals, Inc.

Nov 27, 2019, 17:00 ET